Search results
Results from the WOW.Com Content Network
The TCAs are used primarily in the clinical treatment of mood disorders such as major depressive disorder (MDD), dysthymia, and treatment-resistant variants. They are also used in the treatment of a number of other medical disorders, including cyclic vomiting syndrome (CVS) and anxiety disorders such as generalized anxiety disorder (GAD), social phobia (SP) also known as social anxiety ...
Worldwide, nearly 300 million adults suffer from this mental health disorder. ... Tricyclic antidepressants (or TCAs) are a type of antidepressant developed in the 20th century.
It is this and its NET-inhibiting action is believed to give amitriptyline its antidepressant action. NET: 22.4: 4.37? See above. DAT: 5380: 3100? 5-HT 1A: 450: 294: 421: Binding for human brain receptors had to be substituted in amitriptyline (AMI) and nortriptyline's (NOR) cases 5-HT 2A: 4.3: 5: 5.6: Binding for cloned rat receptors had to be ...
Nortriptyline is a tricyclic compound, specifically a dibenzocycloheptadiene, and possesses three rings fused together with a side chain attached in its chemical structure. [43] Other dibenzocycloheptadiene tricyclic antidepressants include amitriptyline (N-methylnortriptyline), protriptyline, and butriptyline.
Maprotiline, sold under the brand name Ludiomil among others, is a tetracyclic antidepressant (TeCA) that is used in the treatment of depression. [5] It may alternatively be classified as a tricyclic antidepressant (TCA), specifically a secondary amine. [5]
Desipramine, sold under the brand name Norpramin among others, is a tricyclic antidepressant (TCA) used in the treatment of depression. [8] It acts as a relatively selective norepinephrine reuptake inhibitor, though it does also have other activities such as weak serotonin reuptake inhibitory, α 1-blocking, antihistamine, and anticholinergic effects.
Heterocyclic antidepressants inhibit the nerve cells' ability to reuptake norepinephrine and serotonin. This group of drugs, once the mainstay of treatment, include: Tricyclic antidepressants; Tetracyclic antidepressants; Tiazesim, an old antidepressant that is tricyclic and heterocyclic.
Monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs) were the first drugs to be developed for the treatment of depression, dating back to the early 1950s. Because of their undesirable adverse-effect profile and high potential for toxicity , due to their non-selective pharmacological effects, strict regimens were needed for ...